Bimatoprost protects retinal neuronal damage via Akt pathway

European Journal of Pharmacology

Volumn 702, Issue 1-3, 2013, Pages 56-61

  Takano, Norihito ^a   Tsuruma, Kazuhiro ^a   Ohno, Yuta ^a   Shimazawa, Masamitsu ^a   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Akt; Bimatoprost; ERK (Extracellular signal regulated kinase); Retinal damage; Retinal ganglion cell

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; BIMATOPROST; GLUTAMIC ACID; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EYE PROTECTION; HISTOPATHOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA GANGLION CELL; RETINA INJURY; RETINA INNER PLEXIFORM LAYER; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AMIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; BUTHIONINE SULFOXIMINE; CELL LINE; CLOPROSTENOL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUTAMIC ACID; MALE; MICE; N-METHYLASPARTATE; OXIDATIVE STRESS; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; RETINAL GANGLION CELLS;

EID: 84875248574     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.01.038     Document Type: Article

References (34)

1. M. Almasieh, A.M. Wilson, B. Morquette, J.L. Cueva Vargas, and A. Di Polo The molecular basis of retinal ganglion cell death in glaucoma Prog. Retin. Eye Res. 31 2012 152 181
2. S.F. Barnett, M.T. Bilodeau, and C.W. Lindsley The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation Curr. Top. Med. Chem. 5 2005 109 125
3. G.W. Bean, and C.B. Camras Commercially available prostaglandin analogs for the reduction of intraocular pressure: similarities and differences Surv. Ophthalmol. 53 Suppl. 1 2008 S69 S84
4. C. Bucolo, S. Salomone, F. Drago, M. Reibaldi, A. Longo, and M.G. Uva Pharmacological management of ocular hypertension: current approaches and future prospective Curr. Opin. Pharmacol. 13 2013 50 55
5. R.M. Burk, and D.F. Woodward A historical perspective and recent advances in prostamide research and therapeutics Curr. Opin. Drug Discov. Dev. 10 2007 413 421
6. S. Cagnol, and J.C. Chambard ERK and cell death: mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence FEBS J. 277 2010 2 21
7. J. Caprioli, Y. Munemasa, J.M. Kwong, and N. Piri Overexpression of thioredoxins 1 and 2 increases retinal ganglion cell survival after pharmacologically induced oxidative stress, optic nerve transection, and in experimental glaucoma Trans. Am. Ophthalmol. Soc. 107 2010 161 165
8. J.W. Cheng, and R.L. Wei Meta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressure Clin. Ther. 30 2008 622 632
9. Z.H. Cheung, Y.M. Chan, F.K. Siu, H.K. Yip, W. Wu, M.C. Leung, and K.F. So Regulation of caspase activation in axotomized retinal ganglion cells Mol. Cell. Neurosci. 25 2004 383 393
10. S.S. Davies, W.K. Ju, A.H. Neufeld, D. Abran, S. Chemtob, and L.J. Roberts 2nd Hydrolysis of bimatoprost (Lumigan) to its free acid by ocular tissue in vitro J. Ocul. Pharmacol. Ther. 19 2003 45 54
11. F. Drago, S. Valzelli, I. Emmi, A. Marino, C.C. Scalia, and V. Marino Latanoprost exerts neuroprotective activity in vitro and in vivo Exp. Eye Res. 72 2001 479 486
12. S.E. Easthope, and C.M. Perry Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension Drugs Aging 19 2002 231 248
13. M. Hernandez, J.H. Urcola, and E. Vecino Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments Exp. Eye Res. 86 2008 798 806
14. W.G. Hodge, J. Lachaine, I. Steffensen, C. Murray, D. Barnes, V. Foerster, T. Ducruet, and A. Morrison The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review Br. J. Ophthalmol. 92 2008 7 12
15. A. Kanamori, M. Naka, M. Fukuda, M. Nakamura, and A. Negi Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo Exp. Eye Res. 88 2009 535 541
16. N. Kinkl, J. Sahel, and D. Hicks Alternate FGF2-ERK1/2 signaling pathways in retinal photoreceptor and glial cells in vitro J. Biol. Chem. 276 2001 43871 43878
17. H. Kudo, T. Nakazawa, M. Shimura, H. Takahashi, N. Fuse, K. Kashiwagi, and M. Tamai Neuroprotective effect of latanoprost on rat retinal ganglion cells Graefes Arch. Clin. Exp. Ophthalmol. 244 2006 1003 1009
18. M.H. Kuehn, J.H. Fingert, and Y.H. Kwon Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies Ophthalmol. Clin. North Am. 18 2005 383 395
19. Y. Liang, D.F. Woodward, V.M. Guzman, C. Li, D.F. Scott, J.W. Wang, L.A. Wheeler, M.E. Garst, K. Landsverk, G. Sachs, A.H. Krauss, C. Cornell, J. Martos, S. Pettit, and H. Fliri Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes Br. J. Pharmacol. 154 2008 1079 1093
20. J.M. Luo, L.P. Cen, X.M. Zhang, S.W. Chiang, Y. Huang, D. Lin, Y.M. Fan, N. van Rooijen, D.S. Lam, C.P. Pang, and Q. Cui PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury Eur. J. Neurosci. 26 2007 828 842
21. J.F. Markworth, and D. Cameron-Smith Prostaglandin F2α stimulates PI3K/ERK/mTOR signaling and skeletal myotube hypertrophy Am. J. Physiol. Cell Physiol. 300 2011 C671 682
22. J.A. Moncaster, D.T. Walsh, S.M. Gentleman, L.S. Jen, and O.I. Aruoma Ergothioneine treatment protects neurons against N-methyl-d-aspartate excitotoxicity in an in vivo rat retinal model Neurosci. Lett. 328 2002 55 59
23. Y. Munemasa, S.H. Kim, J.H. Ahn, J.M. Kwong, J. Caprioli, and N. Piri Protective effect of thioredoxins 1 and 2 in retinal ganglion cells after optic nerve transection and oxidative stress Invest. Ophthalmol. Vis. Sci. 49 2008 3535 3543
24. Y. Nakanishi, M. Nakamura, H. Mukuno, A. Kanamori, G.M. Seigel, and A. Negi Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase Exp. Eye Res. 83 2006 1108 1117
25. N.N. Osborne, D. Ji, A.S. Abdul Majid, R.J. Fawcett, A. Sparatore, and P. Del Soldato ACS67, a hydrogen sulfide-releasing derivative of latanoprost acid, attenuates retinal ischemia and oxidative stress to RGC-5 cells in culture Invest. Ophthalmol. Vis. Sci. 51 2010 284 294
26. J.W. Ramos The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells Int. J. Biochem. Cell Biol. 40 2008 2707 2719
27. H.P. Reusch, S. Zimmermann, M. Schaefer, M. Paul, and K. Moelling Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells J. Biol. Chem. 276 2001 33630 33637
28. T.P. Rygiel, A.E. Mertens, K. Strumane, R. van der Kammen, and J.G. Collard The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation J. Cell Sci. 121 2008 1183 1192
29. N.A. Sharif, C.R. Kelly, J.Y. Crider, G.W. Williams, and S.X. Xu Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells J. Ocul. Pharmacol. Ther. 19 2003 501 515
30. J. Stjernschantz, and A. Alm Latanoprost as a new horizon in the medical management of glaucoma Curr. Opin. Ophthalmol. 7 1996 11 17
31. R. Uchibayashi, K. Tsuruma, Y. Inokuchi, M. Shimazawa, and H. Hara Involvement of Bid and caspase-2 in endoplasmic reticulum stress- and oxidative stress-induced retinal ganglion cell death J. Neurosci. Res. 89 2011 1783 1794
32. R. van der Valk, C.A. Webers, T. Lumley, F. Hendrikse, M.H. Prins, and J.S. Schouten A network meta-analysis combined direct and indirect comparisons between glaucoma drugs to rank effectiveness in lowering intraocular pressure J. Clin. Epidemiol. 62 2009 1279 1283
33. D.F. Woodward, A.H. Krauss, J. Chen, R.K. Lai, C.S. Spada, R.M. Burk, S.W. Andrews, L. Shi, Y. Liang, K.M. Kedzie, R. Chen, D.W. Gil, A. Kharlamb, A. Archeampong, J. Ling, C. Madhu, J. Ni, P. Rix, J. Usansky, H. Usansky, A. Weber, D. Welty, W. Yang, D.D. Tang-Liu, M.E. Garst, B. Brar, L.A. Wheeler, and L.J. Kaplan The pharmacology of bimatoprost (Lumigan) Surv. Ophthalmol. 45 Suppl. 4 2001 S337 S345
34. J. Zheng, X. Feng, L. Hou, Y. Cui, L. Zhu, J. Ma, Z. Xia, W. Zhou, and H. Chen Latanoprost promotes neurite outgrowth in differentiated RGC-5 cells via the PI3K-Akt-mTOR signaling pathway Cell. Mol. Neurobiol. 31 2011 597 604